...
首页> 外文期刊>International Journal of Biological Macromolecules: Structure, Function and Interactions >Anticlastogenic activity exhibited by botryosphaeran, a new exopolysaccharide produced by Botryosphaeria rhodina MAMB-05
【24h】

Anticlastogenic activity exhibited by botryosphaeran, a new exopolysaccharide produced by Botryosphaeria rhodina MAMB-05

机译:红曲霉MAMB-05产生的一种新的胞外多糖-灰葡萄球菌展现出的抗成软骨活性。

获取原文
获取原文并翻译 | 示例

摘要

Biopolymers such as exopolysaccharides (EPS) are produced by microbial species and possess unusual properties known to modify biological responses, among them are antimutagenicity and immunomodulation. Botryosphaeran, a newly described fungal (1-->3; 1-->6)-beta-D-glucan produced by Botryosphaeria rhodina MAMB-05, was administered by gavage to mice at three doses (7.5, 15 and 30mg/kg b.w.per day) over 15 days, and found to be non-genotoxic by the micronucleus test in peripheral blood and bone marrow. Botryosphaeran administered at doses of 15 and 30mg EPS/kg b.w. decreased significantly (p < 0.001) the clastogenic effect of cyclophosphamide-induced micronucleus formation resulting in a reduction of the frequency of micronucleated cells of 78 and 82% in polychromatic erythrocytes of bone marrow, and reticulocytes in peripheral blood, respectively. The protective effect was dose-dependent, and strong anticlastogenic activity was exerted at low EPS doses. Variance analysis (ANOVA) showed no significant differences (p < 0.05) among the median body weights of the groups of mice treated with botryosphaeran during experiments evaluating genotoxic and protective activities of botryosphaeran. This is the first report on the biological activity attributed to botryosphaeran. (C) 2007 Elsevier B.V. All rights reserved.
机译:诸如胞外多糖(EPS)的生物聚合物是由微生物产生的,并且具有改变生物应答的已知异常特性,其中包括抗突变性和免疫调节作用。以三种剂量(7.5、15和30mg / kg)通过强饲法对鼠李糖单胞菌MAMB-05产生的一种新描述的真菌(1-> 3; 1-> 6)-β-D-葡聚糖进行了灰霉病超过15天),并且通过外周血和骨髓中的微核试验发现无遗传毒性。以15和30mg EPS / kg b.w.的剂量施用Botryosphaeran。显着降低(p <0.001)环磷酰胺诱导的微核形成的致胶化作用,从而导致骨髓多色红细胞和外周血网织红细胞的微核细胞频率分别降低78%和82%。保护作用是剂量依赖性的,在低EPS剂量下具有很强的抗成弹性活性。方差分析(ANOVA)显示,在评估灰霉病菌的遗传毒性和保护活性的实验过程中,用灰霉病菌处理的小鼠组中位体重之间无显着差异(p <0.05)。这是有关灰霉病菌生物学活性的首次报道。 (C)2007 Elsevier B.V.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号